Efficacy and Safety Of AOP2014/P1101, a Novel, Investigational Mono-Pegylated Proline-Interferon Alpha-2b, In Patients With Polycythemia Vera (PV): Update On 51 Patients From The Ongoing Phase I/II Peginvera StudyHeinz Gisslinger, Richard Greil, Daniel Lechner et al.|Blood|2013Cited by 9
AOP2014, a Novel Peg-Proline-Interferon Alpha-2b with Improved Pharmacokinetic Properties, Is Safe and Well Tolerated and Shows Promising Efficacy in Patients with Polycythemia Vera (PV)Heinz Gisslinger, Josef Thaler, Róbert Královics et al.|Blood|2012Cited by 5
Analysis Of Molecular Responses and Chromosomal Aberrations In Patients With Polycythemia Vera Treated With Peg-Proline-Interferon Alpha-2b (AOP2014/P1101) In The Peginvera StudyNicole C.C. Them, Róbert Královics, Heinz Gisslinger et al.|Blood|2013Cited by 3
Open-Label, Prospective, Multicentre, Phase I/II Study of AOP2014, a Novel PEG-Proline-Interferon Alpha-2b in Patients with Polycythemia Vera: Update from an Ongoing StudyHeinz Gisslinger, Josef Thaler, Róbert Královics et al.|Blood|2011Cited by 2